Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO

Author:

Meier Christian1,Uebelhart Brigitte2,Aubry-Rozier Brengre3,Birkhuser Martin4,Bischoff-Ferrari Heike A5,Frey Diana6,Kressig Reto W7,Lamy Olivier3,Lippuner Kurt8,Stute Petra9,Suhm Norbert10,Ferrari Serge2

Affiliation:

1. Division of Endocrinology, Diabetology and Metabolism, University Hospital and University of Basel, Switzerland

2. Service of Bone Diseases, University Hospitals and Faculty of Medicine of Geneva, Switzerland

3. Centre of Bone Diseases, Lausanne University Hospital, Switzerland

4. Gynaecological Endocrinology and Reproductive Medicine, University of Berne, Basel, Switzerland

5. Department of Geriatrics and Aging Research, University of Zurich and University Hospital of Zurich, Switzerland

6. Division of Rheumatology, University Hospital Zürich, Switzerland

7. University Centre for Medicine of Aging, Basel Mobility Centre, University of Basel, Switzerland

8. Department of Osteoporosis, University Hospital and University of Berne, Switzerland

9. Division of Gynaecological Endocrinology and Reproductive Medicine, Women's University Hospital, Berne, Switzerland

10. Department of Orthopaedics and Traumatology, Geriatric Fracture Centre, University Hospital Basel, Switzerland

Publisher

EMH Swiss Medical Publishers, Ltd.

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3